Skip to main content

Susana Otero Romero

Institutions of which they are part

Head of group
Epidemiology and Public Health
Vall Hebron Institut de Recerca
Allergology
General Hospital

Research lines

Clinical epidemiology of Multiple Sclerosis

To characterize the epidemiology of multiple sclerosis (MS) in Catalonia, a prospective registry of new cases of MS in Catalonia was set up in 2009 with the participation of 21 hospitals throughout Catalonia. Prevalence and incidence studies based on this population-based registry are being performed. Recently, and in collaboration with the Center of Multiple Sclerosis of Catalonia (Cemcat), we have set up a prospective registry of vaccination in patients with Immuno-Mediated Inflammatory Disease (IMID) who are candidates for biological treatment with the aim of evaluating vaccine immunogenicity and safety that will allow establishing the best vaccination strategy. In addition, we will study the prevalence and impact of comorbidity on Multiple Sclerosis prognosis.

IP: Susana Otero Romero

Projects

DRIVE

IP: Susana Otero Romero
Collaborators: Ingrid Carbones Fargas, Eva del Amo Moran, Constanza Olivares Castillo
Funding agency: The Innovative Medicines Initiative
Funding: 164597.5
Reference: DRIVE_IMI2-2021
Duration: 01/10/2021 - 30/09/2022

Measuring brand-specific influenza vaccine effectiveness

IP: Susana Otero Romero
Collaborators: Eva del Amo Moran, Magda Campins Martí, Cristina Andrés Vargés
Funding agency: The Innovative Medicines Initiative
Funding: 75438
Reference: DRIVE_IMI2-2020_SUBART11
Duration: 20/07/2020 - 30/09/2021

Measuring brand-specific influenza vaccine effectiveness

IP: Susana Otero Romero
Collaborators: Eva del Amo Moran, Magda Campins Martí, Cristina Andrés Vargés
Funding agency: The Innovative Medicines Initiative
Funding: 69562.5
Reference: DRIVE_IMI2-2019_SUBART11
Duration: 24/10/2019 - 24/10/2020

Estudio de comorbilidad y de inmunogenicidad vacunal en una cohorte prospectiva de pacientes con primeros brotes sugestivos de Esclerosis Múltiple

IP: Susana Otero Romero
Collaborators: Juliana Esperalba Esquerra, Mar Tintore Subirana, Laia Pinos Tella, Marta Rodríguez Barranco, Luciana Midaglia Fernandez, Sonia Maria Uriona Tuma, Anna Laura Salerno
Funding agency: Instituto de Salud Carlos III
Funding: 105270
Reference: PI19/01606
Duration: 01/01/2020 - 31/12/2022

Related news

A l'estudi hi participaran 200 persones voluntàries i es durà a terme a 10 hospitals espanyols, entre els quals Vall d’Hebron.

Entre els projectes més rellevants en Covid-19 destaca la participació del VHIR en assaigs clínics per provar l’eficàcia i seguretat de vacunes com ara Janssen, Pfizer-BioNTech en el col·lectiu d’embarassades, i Hipra.

The trial, which already has AEMPS authorisation, will be conducted in Spain, Portugal and Italy.

Related professionals

Marta  Perea Ortueta

Marta Perea Ortueta

Psychiatry, Mental Health and Addictions
Read more
Lucas Rivera Sánchez

Lucas Rivera Sánchez

Read more
Joaquin Balsells Valls

Joaquin Balsells Valls

Read more
Ramón Vilallonga Puy

Ramón Vilallonga Puy

General Surgery
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.